To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 208,285 shares, the number of shares held decreased 8.36% compared to the previous period and now represents 2.73% of the total position.
      52Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 455,147 shares, the number of shares held decreased 8.36% compared to the previous period and now represents 1.62% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Personalis by 103,873 shares, the number of shares held decreased 8.36% compared to the previous period and now represents 0.88% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Kymera Therapeutics, Inc. by 9,317 shares, the number of shares held decreased 8.34% compared to the previous period and now represents 0.57% of the total position.
      10Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 208,593 shares, the number of shares held decreased 8.36% compared to the previous period and now represents 2.86% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Freenome, Inc. by 158,697 shares, the number of shares held decreased 8.36% compared to the previous period and now represents 1.08% of the total position.
      31Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 1,413,951 shares, the number of shares held decreased 8.36% compared to the previous period and now represents 2.88% of the total position.
      138Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 203,973 shares, the number of shares held decreased 8.36% compared to the previous period and now represents 5.36% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 80,850 shares, the number of shares held decreased 8.36% compared to the previous period and now represents 1.88% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 1,030,057 shares, the number of shares held decreased 8.27% compared to the previous period and now represents 1.26% of the total position.
      4.66K1
      Report
       
       
       
       

      Most Discussed